Back to today’s briefing

Story perspectives

Ambroxol Shows Promise Against Dementia in Parkinson's Patients

7/8/2025

42 5

Summary

Story summary

Researchers at Lawson Research Institute are exploring the potential of Ambroxol, a cough medicine, to combat dementia in Parkinson's patients. In a promising 12-month trial involving 55 participants, Ambroxol proved safe and helped stabilize psychiatric symptoms, while those on a placebo experienced decline. This breakthrough brings hope for innovative treatments, particularly for those genetically predisposed to cognitive decline.

1 of 1

Story summary

Researchers at Lawson Research Institute are exploring the potential of Ambroxol, a cough medicine, to combat dementia in Parkinson's patients. In a promising 12-month trial involving 55 participants, Ambroxol proved safe and helped stabilize psychiatric symptoms, while those on a placebo experienced decline. This breakthrough brings hope for innovative treatments, particularly for those genetically predisposed to cognitive decline.